Free Essay

Wgu - Biochemistry


Submitted By theale1
Words 4886
Pages 20
Hindawi Publishing Corporation
International Journal of Hepatology
Volume 2012, Article ID 487480, 6 pages doi:10.1155/2012/487480 Review Article
Acute Liver Failure Caused by Amanita phalloides Poisoning
Luca Santi,1 Caterina Maggioli,1 Marianna Mastroroberto,2 Manuel Tufoni,1
Lucia Napoli,1 and Paolo Caraceni1
1 U.O.

Semeiotica Medica, Department of Clinical Medicine, Alma Mater Studiorum University of Bologna,
Via Albertoni 15, 40138 Bologna, Italy
2 S.S.D. Liver Transplant, Department of Clinical Medicine, Alma Mater Studiorum University of Bologna,
Via Albertoni 15, 40138 Bologna, Italy
Correspondence should be addressed to Paolo Caraceni,
Received 4 May 2012; Accepted 11 May 2012
Academic Editor: Bruno Nardo
Copyright © 2012 Luca Santi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Mushroom poisoning is a relatively rare cause of acute liver failure (ALF). The present paper analyzes the pathogenesis, clinical features, prognostic indicators, and therapeutic strategies of ALF secondary to ingestion of Amanita phalloides, which represents the most common and deadly cause of mushroom poisoning. Liver damage from Amanita phalloides is related to the amanitins, powerful toxins that inhibit RNA polymerase II resulting in a deficient protein synthesis and cell necrosis. After an asymptomatic lag phase, the clinical picture is characterized by gastrointestinal symptoms, followed by the liver and kidney involvement.
Amatoxin poisoning may progress into ALF and eventually death if liver transplantation is not performed. The mortality rate after
Amanita phalloides poisoning ranges from 10 to 20%. The management of amatoxin poisoning consists of preliminary medical care, supportive measures, detoxification therapies, and orthotopic liver transplantation. The clinical efficacy of any modality of treatment is difficult to demonstrate since randomized, controlled clinical trials have not been reported. The use of extracorporeal liver assist devices as well as auxiliary liver transplantation may represent additional therapeutic options.

1. Introduction
Acute liver failure (ALF) can be caused by the ingestion of mushrooms containing exceptionally powerful hepatotoxins [1]. Among mushroom intoxications, the amatoxin syndrome is of primary importance because it accounts for about 90% of fatalities [2]. It is characterized by an asymptomatic incubation period followed by the gastrointestinal and hepatotoxic phases, leading eventually to multiorgan failure and death.
Although the exact incidence of mushroom poisoning is not precisely estimated due to a presumably relatively high number of underreporting cases, amatoxin poisoning is a worldwide problem. Approximately 50–100 fatal cases are reported every year in Western Europe, being less common in the United States; however, cases of amatoxin poisoning from Africa, Asia, Australia, and Central and South America have been also described [1, 2].

Amatoxin poisoning is caused by mushroom species belonging to three genera Amanita, Galerina, and Lepiota, with the majority of the fatalities attributable to Amanita phalloides, commonly known as the death cap [3] (Figure 1).
Being the most common and deadly cause of mushroom poisoning, the present paper analyzes the pathogenesis, clinical features, prognostic indicators, and therapeutic strategies of ALF secondary to Amanita phalloides intoxication.

2. Mechanism of Amanita Toxicity and
Pathogenesis of Liver Injury
The toxicity of Amanita phalloides is related to two distinct groups of toxins: phallotoxins and amatoxins.
The phallotoxins consist of at least seven compounds, all of which have seven similar peptide rings. Their toxicity reside in the thiamide bond of the sulphur atom located on


International Journal of Hepatology proximal convoluted tubules of kidney, are disproportionately affected.
Among other potential toxic mechanisms, it has been proposed that alpha-amanitin acts in synergy with endogenous cytokines (e.g., tumor necrosis factor) and that this might cause cell damage through the induction of apoptosis

3. Clinical Features and Diagnosis

Figure 1: Image of the mushroom Amanita phalloides, commonly known as the death cap.

the indole ring. These toxins cause damage of the cellular membrane of the enterocytes and are therefore responsible of the initial gastrointestinal symptoms of nausea, vomiting, and diarrhea exhibited by almost all the patients. Even if phallotoxins are highly toxic to liver cells, they add little to the Amanita phalloides toxicity as they are not adsorbed from the intestine and do not reach the liver [4].
The amatoxins are bycyclic octapeptides, formed by at least nine different compounds [5]. Of the amatoxins, αamanitin is the main component and along with β-amanitin is likely responsible for the toxic effect [6, 7]. They are not destroyed by cooking and can be still present in the mushroom after long periods of cold storage [8]. The lethal dose is very low: as little as 0.1 mg/kg body weight may be lethal in adults and this amount can be adsorbed even by ingesting a single mushroom.
Amanitins are adsorbed through the intestinal epithelium and bind weakly to serum proteins. The liver is the principal organ affected, as it is the first organ encountered after absorption in the gastrointestinal tract [9]. Once in the liver, amanitins are transported by a nonspecific transport system into hepatocytes, producing an extensive centrolobular necrosis [4, 10]. About 60% of absorbed α-amanitin is excreted into the bile and is returned to the liver via the enterohepatic circulation [4, 11–15]. However, other organs, especially the kidney, are susceptible to their toxicity.
Amatoxins are not significantly protein bound and are cleared from plasma within 48 h of ingestion [16, 17]. They are filtered by the glomerulus and reabsorbed by the renal tubules, resulting in acute tubular necrosis [18]. Finally, in animal and human post-mortem studies, cellular damage also has been found in the pancreas, adrenal glands, and testes [19, 20].
Amanitins directly interact with the enzyme RNA polymerase II in eucaryotic cells and inhibit the transcription, causing a progressive decrease in mRNA, deficient protein synthesis, and cell death. For this reason, metabolically active tissues dependent on high rates of protein synthesis, such as the cells of the gastrointestinal tract, hepatocytes, and the

The clinical picture due to Amanita phalloides poisoning can range from a mild subclinical presentation to a lethal fulminant course. As a result, not all patients with Amanita phalloides poisoning develop ALF and have a fatal outcome.
The overall severity of the intoxication depends on the amount of toxin ingested and the time elapsed between ingestion and initiation of treatment.
The clinical picture of Amanita phalloides intoxication is classically divided into four consecutive phases (Table 1).
(1) Lag Phase. As the toxins are not irritating by themselves, the initial phase is characterized by the absence of any signs or symptoms. The incubation time goes from 6 to 40 hours with an average of about 10 hours. It is important for an early diagnosis to suspect amatoxin intoxication in any case of a relatively prolonged latency period between mushroom ingestion and onset of symptoms, since other toxic mushrooms that do not cause liver involvement usually induce gastrointestinal symptoms much earlier, 1-2 h after ingestion [1, 2, 4, 10, 21].
(2) Gastrointestinal Phase. This phase is characterized by nausea, vomiting, crampy abdominal pain, and severe secretory diarrhea. Both diarrhea and emesis may become grossly bloody. This gastroenteritic phase may be severe enough to result in acid-base disturbances, electrolyte abnormalities, hypoglycemia, dehydration, and hypotension. This second stage lasts 12 to 24 h. After few hours, the patient seems to be clinically improving, if correction of the dehydration has been achieved. Liver and kidney function tests are usually normal at this point of the illness. If the association with toxic mushrooms is not made, these patients may be erroneously diagnosed with gastroenteritis and discharged home if hospitalized [1, 2, 4, 10, 21].
(3) Apparent Convalescence. 36–48 h after ingestion, signs of liver involvement may appear. In this third stage, despite the apparent improvement of gastrointestinal symptoms, the effects of toxins are damaging both the liver and kidneys, resulting in a progressive deterioration of liver enzyme tests with an increase of serum transaminases and lactic dehydrogenase. Clinical evidences of liver involvement ultimately develop with the onset of jaundice.
(4) Acute Liver Failure. In the last phase, the transaminases rise dramatically and liver and renal function deteriorate, resulting in hyperbilirubinemia, coagulopathy, hypoglycemia, acidosis, hepatic encephalopathy, and hepatorenal syndrome [22]. Multiorgan failure, disseminated intravascular coagulation, mesenteric thrombosis, convulsions, and death may result within 1–3 weeks after ingestion [23]. In contrast, in those patients with a favourable outcome, a rapid

International Journal of Hepatology


Table 1: Criteria for urgent liver transplantation in patients with ALF. Only Ganzert’s criteria are developed specifically for Amanita phalloide poisoning. Clichy’s criteria

King’s College criteria for nonparacetamol causes

King’s College criteria for paracetamol causes

Ganzert’s criteria

Escudie’s criteria

(a) Combination of a decrease in factor V below 30% of normal in patients over 30 years or below 20% of normal in patients below 30 years
(b) Grade 3-4 en cephalopathy
(a) Prothrombin time over 100 s (≈INR over 7) or
(b) At least three of the following criteria:
(i) prothrombin time over 50 sec (INR over 3.5),
(ii) serum bilirubin over 300 μmol/L,
(iii) age below 10 years or over 40 years,
(iv) an interval between jaundice and encephalopathy over 7 days,
(v) drug toxicity
(a) Arterial pH below 7.3 or arterial lactate above 3 mmol/L after adequate fluid resuscitation or (b) Concurrently, serum creatinine above 300 μmol/L, INR above 6.5 and encephalopathy of grade 3 or more (a) A decrease in prothrombin index below or equal to 25% of normal at any time between day 3 and day
10 after ingestion in association with
(b) Serum creatinine over or equal to 106 μmol/L within the same time period
Prothrombin index below 10% of normal (INR of ≈6) 4 days or more after ingestion

improvement in liver function tests occurs, followed by a full recovery and restoration of a normal quality of life.
Diagnosis is based on a careful assessment of history and clinical manifestations and can be confirmed by laboratory tests. The first task is to link the clinical presentation with mushroom ingestion, as the association may be obscured by the delay between symptom onset and the mushroom meal. When interviewing patients or the patient’s relatives suspected of suffering from mushroom poisoning, physicians must obtain a detailed history concerning the ingestion. Key questions include the description of the eaten mushroom, the environment from which it was harvested, the number of different types of mushrooms ingested, the storage before consumption, the preparation before ingestion, the onset of similar symptoms in people who have eaten the same mushroom and the time frame between the mushroom ingestion and the onset of symptoms. Amanitins are resistant to heat and are still active after long periods of storage.
Thus, in contrast to other toxins or bacterial contamination, cooking or prolonged cold storage may exclude other causes of mushroom intoxication, but not poisoning due to
Amanita phalloides [10, 24].
Analysis of amatoxin levels in serum is not available for routine use in the clinical setting. The only specific laboratory test available is the detection of amatoxins in the urine. The role of this analysis is to confirm or exclude the diagnosis, not to grade the severity. We can use different methods of analysis (RIA, ELISA, HPLC), which are highly sensitive, without false negatives if performed in the first 48 h after ingestion [23, 25]. These procedures for alpha-amanitin urine are quite diffuse and not available only in specialized centers. Unfortunately, longer times can invalidate the accuracy of urine analysis. Furthermore, the relationship between

the urinary concentration of α-amanitin and the severity of the liver damage is very weak [1].
Finally, the identification by a mycologist of any remaining mushrooms can be crucial for diagnosis.

4. Treatment Strategies
No specific amatoxin antidote is available. The clinical efficacy of any modality of treatment for amatoxin poisoning is difficult to demonstrate since randomized, controlled clinical trials have not been reported.
The management of amatoxin poisoning consists of preliminary medical care, supportive measures, specific therapies, and liver transplantation. The specific treatments consist of detoxication procedures and chemotherapies. A complete analysis of the world experience in treatment of amatoxin poisoning was published in 2002 by Enjalbert et al. [2].
4.1. Preliminary Medical Care. Preliminary medical care consists of gastrointestinal decontamination procedures. The effectiveness of these treatments is closely related to an early execution. Because of the long asymptomatic latency, the clinical utility of these measures seems to be quite limited.
Data to support or exclude the use of the emesis induced by ipecac syrup administration are insufficient, as well as for the use of whole bowel irrigation. Gastric lavage should be considered only when it could be performed early after ingestion [2].
4.2. Supportive Measures. The first goal should be directed to treat dehydration, electrolyte abnormalities, and metabolic

4 acidosis caused by the gastrointestinal phase of the intoxication.
4.3. Specific Measures
4.3.1. Detoxification Procedures. Detoxification procedures consist of two different approaches: the reduction of intestinal absorption and enhancement of excretion.
(1) Oral Detoxification. Repeated activated charcoal administration should avoid reabsorption of the toxins due to their enterohepatic circulation, although there is no evidence that its use improves clinical outcome. Gastroduodenal aspiration through a nasogastric tube has been recommended as a sole technique or combined with activated charcoal to remove bile fluids and interrupt enterohepatic circulation, but the actual benefit of these procedures is not documented. If diarrhea has ceased, the use of cathartics is recommended [2, 21].
(2) Urinary Detoxification. Intense forced neutral diuresis is no longer recommended, with urinary output of 100–
200 mL/h for 4-5 days being sufficient to increase the renal elimination of amatoxins.
(3) Extracorporal Purification Procedures. Treatment with the Molecular Adsorbent Recirculating System (MARS) has been recently described [26]. Although the real efficacy of this method, or that of the other liver support systems, should be analyzed in appropriate trials, their use may represent a potential additional option to treat patients with severe amanitina poisoning. MARS is a modified dialytic method that mimics the biological features of the hepatocyte membrane by transferring protein-bound and water-soluble toxic metabolites from the blood stream into a dialysate compartment via a special membrane. The method was shown to be efficient in improving liver function by continuously removing protein-bound substances [27]. However, it is generally accepted that extracorporeal decontamination treatment is useful only if started very early, soon after the gastrointestinal symptoms occur [28].
4.3.2. Chemotherapies. According to retrospective data, most authors indicate that silibinin and N-acetylcysteine (NAC) may be effective in the management of patients with
Amanita phalloides poisoning [1, 2, 4, 21]. Many other drugs were used in the past for amatoxin poisoning: antibiotics, antioxidants, thioctic acids, hormones, and steroids: all have been abandoned.
Silibinin, a water soluble silymarin derivate, competes with amatoxins for transmembrane transport and inhibits the penetration of amanitin into hepatocytes, thus having direct hepatoprotective effect [29]. Moreover, silibinin appears to affect also the secondary uptake in the liver mediated through an enterohepatic recirculation.
Administration of silibinin is recommended if the patient is seen within 48 hours of ingestion. The doses are 20–
50 mg/kg/day intravenously and treatment should be continued for 48–96 hours. Silymarin capsules may also be given in dose from 1.4 to 4.2 g/d orally [30, 31].
Penicillin G seems to have a similar mechanism of action, displacing amanitin from the binding to plasma protein

International Journal of Hepatology and thus promoting its excretion and preventing its hepatic uptake [29]. Penicillin G is used in continuous intravenous administration of high doses of Na/K penicillin G
(1,000,000 IU/kg for the first day, then 500,000 IU/kg for the next two days) [30]. Although combined treatment with silibinin and penicillin has been suggested, there are no clinical data to support that this approach is superior to monotherapy with silibinin [1].
Data suggesting hepatoprotection by antioxidants support the use of free radical scavengers, such as N-acetylcisteine (NAC), in the management of amatoxin intoxication
[32]. NAC is used in many centers in patients with ALF not induced by paracetamol and its administration has been proposed also in cases of amatoxin poisoning although the data are quite limited. N-acetylcysteine is usually administered intravenously in 5% dextrose, but 0.9% saline may be also used. The suggested dosage is 150 mg/kg over 15 min intravenously, followed by 50 mg/kg over 4 hours intravenously, followed by 100 mg/kg over 16 hours intravenously. Infusion of the initial dose over 30 to 60 minutes (rather than 15 minutes) may reduce incidence of anaphylactoid reactions
[33, 34].
4.4. Liver Transplantation and Prognostic Indicators. Amatoxin poisoning may progress into ALF and eventually death, if liver transplantation (LT) is not performed. On the basis of the available data, the mortality rate after Amanita phalloides poisoning ranges from 10 to 20% [2, 29, 30]. Patients with severe liver injury should be admitted to Intensive Care Unit connected to a liver transplant centre.
Two surgical options, orthotopic liver transplantation
(OLT) and auxiliary partial liver transplantation (APOLT), have been developed. OLT is a well-established procedure requiring long immunosuppression to prevent graft rejection. Because some patients with partial hepatectomy and temporary support may have complete morphological and functional recovery of their own liver, APOLT can represent an alternative approach. In APOLT, only a portion of the native liver is removed and the remainder is left in situ; the transplant provides temporary assistance until the native liver recovers and the immunosuppression can be withdrawn. The major dilemma in patients with ALF is to find the right timing for transplantation. If the surgical procedure is performed too early, the patient could have survived without impaired quality of life. If the search for a liver graft starts too late, the patient may die before a suitable donor organ becomes available. Several sets of criteria to decide the timing of liver transplantation in patients with ALF have been proposed, although they are not universally accepted
(Table 2). Since the number of patients with amatoxin poisoning evaluated for LT is quite small, the prognostic indicators are not clearly defined in this specific condition.
The most widely used criteria for urgent LT in patients with ALF are those of the King’s College Hospital described by O’Grady et al. [35] which include different parameters for paracetamol and nonparacetamol induced ALF. These criteria are based on prothrombin time (PT), age, etiology, time elapsing between appearance of jaundice and onset of

International Journal of Hepatology

Table 2: Clinical phases of the Amatoxin syndrome.

Stage 1. Lag phase
Stage 2. Gastrointestinal phase
Stage 3. Apparent convalescence
Stage 4. Acute liver failure

Onset from ingestion
0–24 h
6–24 h
24–72 h
4–9 days

Symptoms and signs
Nausea, vomiting, crampy abdominal pain, and severe secretory diarrhea
Asymptomatic, worsening of hepatic and renal function indices
Hepatic and renal failure → multiorgan failure → death

encephalopathy, and bilirubin concentration. In contrast, the
Clichy criteria for urgent LT are based on Factor V, age, and encephalopathy [36].
However, some of these criteria cannot be easily transferred in patients with amatoxin poisoning. Ganzert et al.
[37] retrospectively analyzed the outcome of a large series of amatoxin intoxication cases and found that predictors of death were the prothrombin index in combination with the serum creatinine level on 3–10 days after ingestion.
However, although the presence of hepatic encephalopathy is an absolute requirement for the diagnosis of ALF in
King’s and Clichy criteria, this clinical manifestation was not adequately investigated in the paper by Ganzert et al. because of “imprecise data in the patient’s records” [37]. Thus, these authors proposed that a patient with amatoxin poisoning should be listed for urgent LT regardless of the presence of hepatic encephalopathy, if the prothrombin index is less than
25% and serum creatinine greater than 106 μmol/L at the third day after ingestion.
Also Escudi´ et al. [38], in a retrospective study including e 27 patients admitted for Amanita phalloides poisoning, suggested that encephalopathy should not be an absolute prerequisite for deciding liver transplantation. Nonetheless, independently of any other variables, a decrease in prothrombin index below 10% of normal (INR > 6) 4 days or more after ingestion should lead to consider urgent
LT. Interestingly, these authors proposed that an interval between the ingestion of toxic mushrooms and the onset of diarrhea shorter than 8 h should prompt an especially careful monitoring because of the high risk of fatal outcome.
Furthermore, data from Enjalbert et al. [2] in patients transplanted for amatoxin poisoning indicate that Factor V was below 20% in all cases except one.
Finally, it should be taken into account that most of studies on the efficacy of prognostic criteria for urgent LT in patients with ALF have been carried out in countries where graft is usually available within a short time. However, the waiting time on the emergency transplant list, if it exists, may be very prolonged in other parts of the world [10], and liver transplant may never be performed in others [39]. In these situations, the use of new therapies (i.e., MARS) could be useful as well as the availability of other surgical techniques, such as APOLT.











[1] C. Karlson-Stiber and H. Persson, “Cytotoxic fungi—an overview,” Toxicon, vol. 42, no. 4, pp. 339–349, 2003.
[2] F. Enjalbert, S. Rapior, J. Nouguier-Soul´ , S. Guillon, N. e Amouroux, and C. Cabot, “Treatment of amatoxin poisoning:


20-Year retrospective analysis,” Journal of Toxicology, vol. 40, no. 6, pp. 715–757, 2002.
J. Bryngil, “Amanita phalloides,” Clinical Toxicology Review, vol. 21, pp. 191–198, 1999.
C. N. Broussard, A. Aggarwal, S. R. Lacey et al., “Mushroom poisoning—from diarrhea to liver transplantation,” American
Journal of Gastroenterology, vol. 96, no. 11, pp. 3195–3198,
J. Vetter, “Toxins of Amanita phalloides,” Toxicon, vol. 36, no.
1, pp. 13–24, 1998.
C. K¨ ppel, “Clinical symptomatology and management of o mushroom poisoning,” Toxicon, vol. 31, no. 12, pp. 1513–
1540, 1993.
R. Dart, “Mushrooms,” in Medical Toxicology, pp. 1719–1735,
Williams & Wilkins, Philadelphia, Pa, USA, 2004.
A. Himmelmann, G. Mang, and S. Schnorf-Huber, “Lethal ingestion of stored Amanita phalloides mushrooms,” Swiss
Medical Weekly, vol. 131, no. 41-42, pp. 616–617, 2001.
P. A. Horgen, A. C. Vaisius, and J. F. Ammirati, “The insensitivity of mushroom nuclear RNA polymerase activity to inhibition by amatoxins,” Archives of Microbiology, vol. 118, no. 3, pp. 317–319, 1978.
K. J. Berger and D. A. Guss, “Mycotoxins revisited: part I,”
Journal of Emergency Medicine, vol. 28, no. 1, pp. 53–62, 2005.
C. Busi, L. Fiume, and D. Costantino, “Amanita toxins in gastroduodenal fluid of patients poisoned by the mushroom,
Amanita phalloides,” New England Journal of Medicine, vol.
300, no. 14, p. 800, 1979.
H. Faulstich, “New aspects of amanita poisoning,” Klinische
Wochenschrift, vol. 57, no. 21, pp. 1143–1152, 1979.
J. Piqueras, “Hepatotoxic mushroom poisoning: diagnosis and treatment,” Mycopathologia, vol. 105, no. 2, pp. 99–110, 1989.
S. Vesconi, M. Langer, and G. Iapichino, “Therapy of cytotoxic mushroom intoxication,” Critical Care Medicine, vol. 13, no. 5, pp. 402–406, 1985.
A. Jaeger, F. Jehl, F. Flesch, P. Sauder, and J. Kopferschmitt,
“Kinetics of amatoxins in human poisoning: therapeutic implications,” Journal of Toxicology, vol. 31, no. 1, pp. 63–80,
L. Fiume, S. Sperti, L. Montanaro, C. Busi, and D. Costantino,
“Amanitins do not bind to serum albumin,” The Lancet, vol. 1, no. 8021, p. 1111, 1977.
H. Faulstich, A. Talas, and H. H. Wellhoner, “Toxicokinetics of labeled amatoxins in the dog,” Archives of Toxicology, vol. 56, no. 3, pp. 190–194, 1984.
R. B. Gibbons, “Mushroom poisoning,” Comprehensive Therapy, vol. 8, no. 12, pp. 33–39, 1982.
A. Manoguerra, “Amanita phalloides—type mushroom poisoning,” Bulletin of San Diego Regional Poison Control Center, vol. 6, p. 1, 1982.
M. Derenzini, C. M. Betts, C. Busi, and L. Fiume, “Ultrastructural changes in β-cells of pancreatic islets in α-amanitinpoisoned mice,” Virchows Archiv B, vol. 28, no. 1, pp. 13–20,

[21] M. Leist, F. Gantner, H. Naumann et al., “Tumor necrosis factor-induced apoptosis during the poisoning of mice with hepatotoxins,” Gastroenterology, vol. 112, no. 3, pp. 923–934,
[22] B. Paaso and D. C. Harrison, “A new look at an old problem: mushroom poisoning. Clinical presentations and new therapeutic approaches,” American Journal of Medicine, vol. 58, no.
4, pp. 505–509, 1975.
[23] P. Sanz, R. Reig, L. Borras, J. Martinez, R. Manez, and J. Corbella, “Disseminated intravascular coagulation and mesenteric venous thrombosis in fatal amanita poisoning,” Human
Toxicology, vol. 7, no. 2, pp. 199–201, 1988.
[24] A. Mas, “Mushrooms, amatoxins and the liver,” Journal of
Hepatology, vol. 42, no. 2, pp. 166–169, 2005.
[25] R. Butera, C. Locatelli, T. Coccini, and L. Manzo, “Diagnostic accuracy of urinary amanitin in suspected mushroom poisoning: a pilot study,” Journal of Toxicology, vol. 42, no. 6, pp. 901–
912, 2004.
[26] X. Wittebole and P. Hantson, “Use of the molecular adsorbent recirculating system (MARS) for the management of acute poisoning with or without liver failure,” Clinical Toxicology, vol. 49, no. 9, pp. 782–793, 2011.
[27] S. R. Mitzner, J. Stange, S. Klammt, P. Peszynski, R. Schmidt, and G. N¨ ldge-Schomburg, “Extracorporeal detoxification o using the molecular adsorbent recirculating system for critically ill patients with liver failure,” Journal of the American
Society of Nephrology, vol. 12, no. 17, pp. S75–S82, 2001.
[28] P. Faybik, H. Hetz, A. Baker et al., “Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning,” Liver
International, vol. 23, no. 3, pp. 28–33, 2003.
[29] L. Sorodoc, C. Lionte, V. Sorodoc, O. Petris, and I. Jaba, “Is
MARS system enough for A. phalloides-induced liver failure treatment?” Human and Experimental Toxicology, vol. 29, no.
10, pp. 823–832, 2010.
[30] K. Hruby, G. Csomos, M. Fuhrmann, and H. Thaler,
“Chemotherapy of Amanita phalloides poisoning with intravenous silibinin,” Human Toxicology, vol. 2, no. 2, pp. 183–195,
[31] H. Faulstich, W. Jahn, and T. Wieland, “Silybin inhibition of amatoxin uptake in the perfused rat liver,” Drug Research, vol.
30, no. 3, pp. 452–454, 1980.
[32] G. E. Sklar and M. Subramaniam, “Acetylcysteine treatment for non-acetaminophen-induced acute liver failure,” Annals of
Pharmacotherapy, vol. 38, no. 3, pp. 498–501, 2004.
[33] L. E. Schmidt and K. Dalhoff, “Risk factors in the development of adverse reactions to N-acetylcysteine in patients with paracetamol poisoning,” British Journal of Clinical Pharmacology, vol. 51, no. 1, pp. 87–91, 2001.
[34] T. Y. K. Chan and J. A. J. H. Critchley, “Adverse reactions to intravenous N-acetylcysteine in Chinese patients with paracetamol (Acetaminophen) poisoning,” Human and Experimental Toxicology, vol. 13, no. 8, pp. 542–544, 1994.
[35] J. G. O’Grady, G. J. M. Alexander, K. M. Hayllar, and R.
Williams, “Early indicators of prognosis in fulminant hepatic failure,” Gastroenterology, vol. 97, no. 2, pp. 439–445, 1989.
[36] J. Bernuau, “Selection for emergency liver transplantation,”
Journal of Hepatology, vol. 19, no. 3, pp. 486–487, 1993.
[37] M. Ganzert, N. Felgenhauer, and T. Zilker, “Indication of liver transplantation following amatoxin intoxication,” Journal of
Hepatology, vol. 42, no. 2, pp. 202–209, 2005. e [38] L. Escudi´ , C. Francoz, J. P. Vinel et al., “Amanita phalloides poisoning: reassessment of prognostic factors and indications for emergency liver transplantation,” Journal of Hepatology, vol. 46, no. 3, pp. 466–473, 2007.

International Journal of Hepatology
[39] J. Bernuau, “Acute liver failure: avoidance of deleterious cofactors and early specific medical therapy for the liver are better than late intensive care for the brain,” Journal of Hepatology, vol. 41, no. 1, pp. 152–155, 2004.


The Scientific
World Journal
Hindawi Publishing Corporation Volume 2014

Research and Practice
Hindawi Publishing Corporation Volume 2014

Journal of

Hindawi Publishing Corporation Diabetes Research
Volume 2014

Hindawi Publishing Corporation Volume 2014

Hindawi Publishing Corporation Volume 2014

International Journal of

Journal of


Immunology Research
Hindawi Publishing Corporation Disease Markers

Hindawi Publishing Corporation Volume 2014

Volume 2014

Submit your manuscripts at BioMed
Research International

PPAR Research
Hindawi Publishing Corporation Hindawi Publishing Corporation Volume 2014

Volume 2014

Journal of


Journal of

Hindawi Publishing Corporation Volume 2014

Complementary and
Alternative Medicine

Stem Cells
Hindawi Publishing Corporation Volume 2014

Hindawi Publishing Corporation Volume 2014

Journal of

Hindawi Publishing Corporation Volume 2014

Hindawi Publishing Corporation Volume 2014


Computational and
Mathematical Methods in Medicine
Hindawi Publishing Corporation Volume 2014


Hindawi Publishing Corporation Research and Treatment
Volume 2014

Hindawi Publishing Corporation Volume 2014

Hindawi Publishing Corporation Volume 2014

Oxidative Medicine and
Cellular Longevity
Hindawi Publishing Corporation Volume 2014

Similar Documents

Premium Essay

Biochemistry Wgu

...This document is designed to help you organize your task as you work through the cohort. Please make a copy of this document, which will then appear in your Google Drive. (See below.) If you would like a tutorial on using Google Drive, please click here. Then insert your work into the copied document as instructed. We recommend you do your work in black, and delete all of the blue text prior to submitting your task. When your document is ready to go, save it as a PDF. You can upload this PDF to Taskstream and submit! Protein Structure A. Insert your original model of an essential amino acid that shows all atoms and bonds in both the backbone and the side chain. Click here to learn how to insert images into a Google Document. (Insert in-text citation here). 1 Characteristics of Leucine: Hydrophobic Oxygenation Insert your description of two characteristics (e.g., reactivity, hydrophobicity, how it affects the structure or functions of a protein) for the amino acid model you created in part A. (Insert in-text citation here). B. Insert your original diagram, or series of original diagrams, of the different levels of protein structure. 1. Check to see that you labeled the primary, secondary, tertiary, and quaternary structures in your diagram(s). Primary Secondary Tertiary quaterrnary (Insert in-text citation here). C. Insert your original diagram, or series...

Words: 656 - Pages: 3

Free Essay

Wgu Biochemistry

...! ! ! ! ! ! Western Governors University Biochemistry GRT Task 5: Lipids, The Importance of Fat in the Diet ! ! ! ! ! ! ! ! ! Melissa Robinson Student ID: 000389892 June 2015
 Fat is often maligned in the media, and is often named “public enemy #1” because of the obesity epidemic that our country has been struggling against for several years. However, fat is an essential component in the human body. Fat must be taken in and used by the body to maintain health. That said, moderation is key. Too much of a good thing, can lead to other health issues, as seen by the obesity level in this country. It is important to strike a balance between healthy consumption of fats that the body needs to function, and the other end of the spectrum, too much fat or no fat at all in the diet. Below is a brief overview of how the body uses fats, known as lipids, in the body and why lipids are essential to the body’s health. A. Energy Stored as Fat Food is often shared with others socially and enjoyed for its taste and aroma. Fatty foods are often considered pleasurable to eat because they provide people with richness of flavor, texture and an overall feeling of satisfaction. However, fat in foods is not just there for pleasure. The body uses fat an energy source. The fat is stored in tissue called “adipose tissue.” A special type of molecule, called a triglyceride, is used by the body to store fat. Triglycerides are used as large, fat storage...

Words: 998 - Pages: 4

Premium Essay

Wgu Grt3 Biochemistry

...Enzymology and Catalytic Mechanisms GRT3 Enzymes are proteins that speed up chemical reactions. They are catalyst. Without catalyst, chemical reactions would still take place, but at a slower rate and the body wouldn’t benefit. All enzymes possess two essential properties. First, enzymes accelerate the rate of chemical reactions without being consumed and/or changed by the reaction. Second, enzymes accelerate reaction rates without changing the chemical equilibrium among reactants and products. Each enzyme has a receptor site, and they are very specific to which molecule (substrate) it will interact with. When a substrate is captured, it will either be combined to create a product or it will be broke down. Fructose is primarily metabolized in the liver. Fructose alone cannot be used as energy. It has to be broke down for use. Enzymes in the liver aid fructose metabolism. Fructose binds to the receptor site on the enzyme fructokinase. This enzyme uses ATP and ADP cycle (energy) to speed up the chemical reaction to convert fructose into Fru-1-p. Next, Fru-1-p will undergo the next reaction and will produce either DHAP or glyceraldehyde by way of the enzyme Aldolase B. (Wikipedia, 2015) As stated above, Aldolase B is active specific to the substrate Fructose-1-Phosphate. Fructose-1-phos is derived from fructose. It’s produced by fructokinase which is available in the liver. It’s converted by aldolase B into dihydroxyacetone phosphate and glyceraldehyde. A deficiency...

Words: 1179 - Pages: 5

Free Essay

Bio Chem Task 2

...Smith 1                          Heather Smith  477126  Biochemistry  WGU  August 24, 2015                                      Smith 2    Model of Essential Amino Acid    Essential amino acids are those amino acids in which the body can not make on its own,  instead they must be procured through the foods that we eat (Helmenstein).  Lysine is one of the  essential amino acids. Two of the​  ​ chemical properties of lysine are that it is positively charged  and it is hydrophilic, which means water loving so it easily dissolves in water (National Center  for Biotechnology Information).            Smith 3  Each NH2 contains one nitrogen atom and two hydrogen atoms­ represented on the diagram as  intertwining pipe cleaners color coded to there respective elements (ie NH2 has blue and neon)    Each CH2 contains one carbon atom and two hydrogen atoms (pink and neon)    OH contains one oxygen atom and one hydrogen atom (orange and neon)        Diagram of Protein Structure              Smith 4                        Dehydration : Creating a Peptide Bond                Smith 5                        Diagram: Peptide Bond Broken by Hydrolysis                Smith 6        The Four Forces that Stabilize Proteins at Tertiary Level      The tertiary structure of proteins are dictated by several factors. Non polar molecules are  also hydroph...

Words: 861 - Pages: 4

Premium Essay

Biochemistry Task 4 Wgu

...Task 4: Metabolism 1. They speed up reactions and do not change themselves, which means they can be used over and over. Enzymes help facilitate chemical reactions. Enzymes will lower the activation energy needed to start the reaction and that is how the reaction will be sped up. Enzymes are specific for certain reactions and are proteins. Not all catalysts though are enzymes. (Sanders, 2014) 2. (Gresham HS IB Biology, 2007) 3. (Hudon-Miller, S. 2012) 4 & 5. When table sugar is consumed, it is broken down into glucose and fructose. Glucose is used in the blood stream. Glucose can be stored in the liver as glycogen. Fructose does enter glycolysis, but first two steps are original to fructose. The first step involves breaking down fructose into fructose-1 phosphate by the enzyme, fructokinase. Fructose is the substrate of fructokinase and it’s product is fructose-1 phosphate. Fructose-1 phosphate is converted into DHAP and glyceraldehyde (products), by the enzyme aldolase B which will enter the glycolysis pathway. (Hudon-Miller, S. 2012) In HFI, there is an aldolase deficiency, so there is no conversion of fructose-1 phosphate into DHAP and glyceraldehyde, so they do not enter the glycolysis pathway to produce ATP or in gluconeogenesis. The fructose is still achieving phosphorylation by fructokinase, which results in a build up of fructose-1 phosphate. The liver cells are unable to utilze fructose as energy. There becomes an abundant buildup of fructose-1...

Words: 756 - Pages: 4

Premium Essay

Wgu Biochemistry Task 5

...1. Lipids to ATP * Hydrolysis is the first step in the breakdown of lipids. This happens in the cytoplasm, to produce fatty acids and glycerol. The glycerol is then metabolized into dihydroxyacetone phosphate. This hydroxyacetone is further metabolized into one of two compounds: pyruvic acid (for energy) or glucose-6-phosphate (during gluconeogenesis). * Fatty acids are catabolized into Acetyl Coenzyme-A, during something called the fatty acid spiral, which is then transformed into ATP, carbon dioxide, and water using the electron transport chain and the citric acid cycle. * ATP is created from both the citric acid cycle and the fatty acid spiral (Brandt, n.d.). 2.  Saturated vs Unsaturated fatty acids  * Saturated fatty acids: carbons are single bonded, solid at room temperature * Unsaturated fatty acids: carbons are double bonded, liquid at room temperature (Fatty Acid, 2015) 1.  Saturated Fatty Acid 2.  Unsaturated Fatty Acid 3. 4.  No-Fat Diets * Non-fat diets are detrimental to the body, because vitamin-D, an essential vitamin, cannot be absorbed without lipids (fats). Vitamin D is essential to the absorption of vitamin C and phosphate. Vitamin C and phosphate are necessary for bone structure, neuromuscular function, and immune function. * Lipids are also necessary for the absorption of estrogen, one of the hormones responsible for reproduction, related to fetal growth and uterine changes during pregnancy. Without fat in the diet...

Words: 298 - Pages: 2

Premium Essay

Biochemistry Task 2 Wgu

...Biochemistry Task 2 Brandy McDowell 000499302 November 30, 2015 A. (Lyman, 2013) B. (Wolfe, 2000) (Wolfe, 2000) B. (Wolfe, 2000) (Wolfe, 2000) C. (Hudon-Miller, 2012) D. (Hudon-Miller, 2012) E. The four forces that stabilize a protein. * Hydrophobic interactions which are interactions by nonpolar amino acids. The weakest of the four types of bonds. * Hydrogen bond made up of interactions of polar or charged amino acids. The amino acids share their hydrogen. This is also a weak bond, but it is stronger than the hydrophobic interaction. * Ionic bonds are made up of charged amino acids. A positive charge of an amino acid attracts to a negative charge of another amino acid. This bond is a little stronger than the hydrogen bond, but not as strong as the polypeptide bond. * Disulfide bond only occurs between two cysteine amino acids. Two cysteine amino acids form a sulfa-sulfa bridge. This is a strong covalent interaction. (Borges, 2014) F1.  Explain the role of prions in BSE, including each of the following: ●How prions are formed – Prions are malformed proteins. Instead of reproducing, the prions cause normal proteins to change to the malformed version. The normal prion (PrPc) is bound to the surface of neurons. PrPc can be altered and become misfolded taking on a different conformation which is then known as PrPsc. ●The connection between misfolding and aggregation – Because the misfolded prions are hydrophobic...

Words: 664 - Pages: 3

Premium Essay

Wgu Biochemistry Task 3

...A. 1. Oxygentated blood has picked up oxygen from the lungs. Deoxygenated blood has had most of its oxygen removed and needs to return to the lungs for re-oxygenation. Oxygenated blood is bright red. Deoxygenated blood is dark red. Oxygenated blood cells have a relaxed shape whereas deoxygenated blood cells have a tense shape. 2. Carbon dioxide concentration decreases as blood nears the lungs, which in return causes and increase in pH . Increased pH causes increased affinity for oxygen which causes the hemoglobin to pick up oxygen entering your blood to be transported to the body’s tissue. Hemoglobin loses hydrogen ions from specific amino acids at key sites as pH rises causing slight changes in its structure that increase its ability to bind oxygen. As pH falls hemoglobin picks up hydrogen ions and its affinity for oxygen decreases. Increasing carbon dioxide concentration in your tissues cause a decrease in pH, which in turn forces hemoglobin to dump the oxygen it's carrying so your cells can use it for energy . a. 3. B. 1. 2. 3. Diseased cells have lower than normal ability to transport oxygen. Sickle cell hemoglobin is stiff and sticky. They stick together and do not flow through vessels easily causing blockages. The blockages caused by sickle cells affect oxygen being transported to tissues in the body. 4. a. Sickle cell disease is an inherited...

Words: 338 - Pages: 2

Premium Essay

Wgu Biochemistry Task 5

...A. Explain how lipids, in the form of triglycerides, are broken down to produce ATP, including ​each​ of the following: Triglycerides are first broken down to fatty acids and glycerol by separating the bond between the glycerol and the fatty acid. The fatty acids undergo beta oxidation and are broken into two carbon units. The carbon subunits generate Acetyl­CoA. (O’Malley 2014) During beta oxidation hydrogen and electrons are removed from the fatty acids and are carried by NADH and FADH2 to the electron transport chain to generate ATP. Acetyl­CoA enters the citric acid cycle which removes electrons and hydrogen. NADH and FADH2 is used to carry the ions to the electron transport chain to form ATP. B. Explain two differences between saturated and unsaturated ​fatty acids​ (not fats). A saturated fatty acids has hydrogen on all points of its chemical chain. Unsaturated fatty acids will have a pair of hydrogen missing on its chain. Saturated fats are solid at room temperature vs liquid for unsaturated. 1. Create ​one​ original 3­D model to demonstrate the chemical structure of a saturated fatty acid. 2. Create one original 3­D model to demonstrate the chemical structure of an unsaturated fatty acid. C. Create an original diagram, with clear labels, to demonstrate the fluid mosaic structure of cell membranes. D. Explain how no­fat diets can affect the body (e.g., nutrient absorption, essential fatty acids), including ​each​ of...

Words: 469 - Pages: 2

Premium Essay

Wgu Biochemistry Task 1

...Biochemistry Task 1 Candy Hughes 000515305 January 1, 2016 A. (Brown, 2010) B (Ly, Sklar, Pesavento, and Sternberg., 2010) C. (Chen, 2010)    (Chen, 2010) D. The death cap mushrooms produce a toxin called Amanita phalloides, this toxin can be fatal to humans. Amatoxins are comprised of a ring of amino acids that hinder the production of specific proteins within liver and kidney cells. Without these proteins, cells can no longer to function adequately. (Fisher and Bennette,2012) Amanita phalloides have the ability to inhibit an enzyme called RNA polymerase II, this enzyme allows mRNA to take place. mRNA is the processes of making a copy of DNA. In the eukaryotic cells, the amanitin toxin directly interacts with an enzyme called RNA polymerase II; thus, decreasing transcription of mRNA (Nardo, 2012). Thus causing cellular death. Reference Chen, P. (2010). Retrieved December 28,2015 from Brown, A. (2010) Theory of Knowledge Biology Topic 3.4 DNA Replication. Retrieved December 27, 2015from Fischer and Bessette. (1992) Edible Wild Mushrooms of North America. retrieved December 28,2015 from Ly, M., Sklar, B., Pesavento, N., and Sternberg, Z. (2010) Retroviruses: What are Retroviruses. Retrieved...

Words: 252 - Pages: 2

Free Essay


...Date Sheet for Sciences General/ Core Courses/All Major Mid Term Examinations -Fall 2013 Semester Date & Day Sem 09:30 -11:00 Sec No. Room No. Teacher's Name Tooba Mohtsham Dr. Shahnaz Ch. Dr. Shahnaz Ch. Sem 11:30 -01:00 Sec No. Room No. Teacher's Name Sem Asifa Kayani Dr. Nikhat Khan 7 7 7 01:30 -03:00 Sec No. Room No. Teacher's Name 1 Introductory Biochemistry Introduction to Biotechnology Molecular Biotechnology A A A 9 35 4 Sci Y Sci Y Sci Y 3 3 Microbiology Electricity and Magnetism A A 56 31 NB-15 NB-8 Data Analysis & Report Writing A Data Analysis & Report Writing B Data Analysis & Report Writing C 33 NB-14 Farah Arif Munaza Bajwa Itrat Batool Naqvi 21-Oct-13 1 5 41 Main Lab NB-7 1 1 English-I English-I N K 25 44 SCI Y SCI Z Sadia Ghaznavi Nasreen Pashsa 3 Mathematics A 28 NB-36 Nighat Altaf 5 Molecular Physiology A 16 SCI 9 SCI 6 SCI 8 SCI 12 SCI 12 Tooba Mohtsham Asifa Kayani Saleha Mehboob Ayesha Aftab Gaitee Joshua 22-Oct-13 Basic Concepts of Environmental Sciences 24 5 A Data Handling and Atomic Spectroscopy 5 A 5 5 Electrical Instrumentation Human and Animal Behavior A A 9 9 12 7 Advanced Topics in Molecular BiologyA 7 7 Medical Biotechnology Plant Ecology A A 19 33 3 SCI 6 SCI R SCI 6 SCI 7 SCI 7 SCI 8 SCI8 Dr.Hooria Younas Dr. Amber Shehzadi Asifa Kayani Ayesha Roohi Saleha Mehboob Saima Mubeen Dr. Saleema...

Words: 918 - Pages: 4

Premium Essay


...Carbohydrates Carbohydrates are the sugars, starches and fibers found in fruits, grains, vegetables and milk products. They are called carbohydrates because, at the chemical level, they contain carbon, hydrogen and oxygen. Carbohydrates provide fuel for the central nervous system and energy for working muscles. Carbohydrates are classified as simple or complex. Simple carbohydrates contain just one or two sugars, such as fructose (fruits) and galactose (milk products). These single sugars are called monosaccharides. Carbs with two sugars — such as sucrose (table sugar), lactose (dairy) and maltose are called disaccharides. Complex carbohydrates, which are also called polysaccharides have three or more sugars. They are often referred to as starchy foods and include beans, lentils, potatoes, corn, whole-grain breads and cereals. Lipids Lipids are molecules that contain hydrocarbons and make up the building blocks of the structure and function of living cells. Examples of lipids include fats, oils, waxes, certain vitamins, hormones and most of the non-protein membrane of cells. Lipids are not soluble in water. They are non-polar and hydrophobic. Lipids contains a functional group including neutral fats, waxes, phospholipids, and glycolipids. The fatty acids with no carbon-carbon double bonds are called saturated. The ones that have two or more double bonds are called polyunsaturated.  Proteins Proteins are large biomolecules, or macromolecules. They are made up of hundreds or...

Words: 371 - Pages: 2

Premium Essay

Macromolecules and Their Parts

...There are four macromolecules that make up all living things. These macromolecules are proteins, carbohydrates, lipids, and nucleic acids. All of these macromolecules are formed from functional groups. The functional group hydroxyl is found in every macromolecule. All of these macromolecules except for lipids are hydrophilic. All of these macromolecules are broken down into monomers by hydrolysis reactions. Proteins have methyl groups, amino groups, and carboxyl groups. Proteins are polymers of amino acids. Proteins functions are determined by how they are folded. Proteins with a primary structure have no function. Proteins with a secondary structure are in the shape of an alpha helix but still have no function. Once a protein achieves tertiary structure that protein has a function. Quaternary structures in proteins are made of many motifs and have the most advanced functions of all the structures, many of them being enzymes due to their three dimensional structure. However, a protein can become unfolded, and once it does it cannot be reversed, this is called denaturation and makes the protein loose its functions. All proteins and polypeptides are links of amino acids held together by peptide bonds. Peptide bonds are formed between two molecules when the carboxyl group and the amino groups in two atoms react which causes dehydration synthesis. Carbohydrates have carbonyl groups, and are organic compounds every time due to the presence of a carbon atom and also have hydrocarbons...

Words: 491 - Pages: 2

Free Essay


...Introduction: Yeast cells are simple, unicellular, eucaryotic organisms belonging to the Fungi kingdom. These cells are particularly important as tools for research because they share structural and compositional similarity with cells of higher organisms. This experiment makes use of these similarities to study individual macromolecular components found within all living cells. Through this experiment we will learn the basic sub-units that make up each of these macromolecules while also learning some of their important structural characteristics. This experiment will consist of two parts. The first of which will divide the yeast cells into three of its major macromolecular components: nucleic acids, proteins and polysaccharides. These components are large macromolecules that are quite unique in their composition, structure and function. However, they share a common feature as each macromolecule is composed of repeating subunits, characteristic of the macromolecule. The subunits are linked together by a bond between two adjacent subunits, formed by the loss of water (condensation). Thus, macromolecules can be broken down by the addition of water across the bond, in a process known as hydrolysis. This process was used in the experimental procedure to allow analysis of each individual macromolecule in its subunit form. Proteins are hydrolyzed into amino acids, nucleic acids are hydrolyzed into sugar, base and phosphate, and polysaccharides are broken down into simple sugars...

Words: 728 - Pages: 3

Free Essay

Empirical Procedure

...Biochemistry Empirical procedure for purifying Enzyme X:     1.   To begin the purification process, mix blue green algae with an appropriate quantity of a buffer and triturate through use of a mechanical crushing process. Centrifuge at 4 degrees C for 10 min at 5,000 rpm. Next, determine whether the supernatant and the precipitate has the highest specific activity of the desired enzyme. The specific activity is the ratio of biochemical activity to the weight or volume of total protein present. The portion containing the greatest concentration of the desired enzyme would be kept for further fractionation and testing. Use of substances such as ammonium sulfate or polyethylene glycol that compete for water with the macromolecules could then be employed. This process, known as "salting out" the organic material from water by varying the solvent ratio or through doing another assay measuring the specific activity. Again, the portion containing the lesser amount would be discarded. Affinity chromatography would next be performed to identify the active enzyme based on the principal that enzymes attach to specific substrates and that specific receptors selectively bind the enzyme, impeding its passage in solution. Next, electrophoresis would be performed to help determine the purity of the compound.  In electrophoresis, substances are first sorted by size and charge, and then by charge. There will be a separation of bands in the electrophoresis that corresponds to the...

Words: 313 - Pages: 2